Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
Abstract Background Babesiosis represents a veterinary and medical threat, with a need for novel drugs. Artemisinin-based combination therapies (ACT) have been successfully implemented for malaria, a human disease caused by related parasites, Plasmodium spp. The aim of this study was to investigate...
Main Authors: | Leonardo J. M. Carvalho, Bunduurem Tuvshintulga, Arifin B. Nugraha, Thillaiampalam Sivakumar, Naoaki Yokoyama |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-020-04235-7 |
Similar Items
-
Failure of an Approximately Six Week Course of Tafenoquine to Completely Eradicate <i>Babesia microti</i> Infection in an Immunocompromised Patient
by: Prithiv J. Prasad, et al.
Published: (2022-09-01) -
Plasma Blood Levels of Tafenoquine following a Single Oral Dosage in BALBc Mice with Acute <i>Babesia microti</i> Infection That Resulted in Rapid Clearance of Microscopically Detectable Parasitemia
by: Dana G. Mordue, et al.
Published: (2023-08-01) -
Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo
by: Amani Magdy Beshbishy, et al.
Published: (2019-05-01) -
Development of unstable resistance to diminazene aceturate in Babesia bovis
by: Bumduuren Tuvshintulga, et al.
Published: (2019-04-01) -
Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo
by: Shengwei Ji, et al.
Published: (2022-01-01)